- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02563743
Stress and Mental Ill-health in the Workplace: Evaluation of an Intervention for the Prevention of Sick Leave
Preventing Sickness Absenteeism Among Employees With Common Mental Disorders and Stress-related Symptoms: a Cluster Randomized Trial of a Problem-solving Based Intervention Versus Care-as-usual Conducted at the Occupational Health Services
Purpose
Common mental disorders (CMD:s) are the leading cause of sick-leave spells in Sweden, resulting in suffering for the individual and financial costs for the employer as well as for society at large. Studies on interventions that address stress and mental ill-health and that focus on sick leave and return to work (RTW) show little or no effect of commonly used methods such as medication or psychological approaches. Furthermore, these interventions often focus on the individual's symptoms without considering their work situation. The occupational health services (OHS) has knowledge of the employee's work environment and can offer treatment facilitating the employee's RTW and improving the employee's work ability while taking into account both the individual and the work situation. The intervention in the current study will be performed at the OHS.
The study aim is two-fold: first, an intervention that addresses both individual and workplace related aspects among employees with work-related CMD:s and/or stress related symptoms will be evaluated. In particular, the treatment's cost-effectiveness and impact on sick leave and mental health will be studied. Secondly, the concerned OHS staff's adherence to the intended treatment and associations with the outcome of the intervention will be assessed.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 14141
- Karolinska Institutet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The employee suffers from stress related symptoms or work-related common mental disorders.
- The employee is either not on sick leave or is on sick leave for a maximum of 3 consecutive months (full or part time).
- The employee understands both written and spoken Swedish.
- The employees nearest supervisor should be aware of the employees visit(s) at the OHS (to avoid differential selection into the experimental and the control condition)
Exclusion Criteria:
- Bullying
- Pregnancy
- Post traumatic stress-disorder
- Severe mental disorders (e.g. psychosis)
- Any co-morbidity that may substantially affect the employee's ability to work and/or quality of life.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Problem-solving based intervention
Problem-solving based intervention with a participative approach.
During the intervention a systematic assessment of the match between the employee and the work environment is considered.
The intervention applies a participatory approach where the supervisor and the employee are guided by the OHS consultant and encouraged to actively take part in problem solving concerning the work situation.
The intervention consists of three meetings, one between the OHS consultant and a representative for the employer (usually the nearest supervisor), one between the consultant and the employee and then a third meeting where all three parties participate.
|
The intervention comprises both the employee and the employer, and follows a clear structure comprising problem solving, stepwise activation and relapse prevention.
It includes three meetings at the OHS with additional follow-ups.
|
Active Comparator: Treatment as usual
The control intervention consists of the usual interventions given at the participating OHS.
These interventions are also work-directed and usually also include participation of both the employee and the supervisor.
However, structured problem solving methods and the systematic consideration of the match between the employee and the job situation are not applied.
The content of the control condition will vary between different occupational health service units.
|
Study participants that are randomized into the control group will receive the usual care given at the OHS.
This intervention will differ due to differences between the OHS units.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in total registered sickness absenteeism during the 12 month follow-up period.
Time Frame: At baseline and 12 months after baseline.
|
(1) Total sick leave in days, register data (sickness benefit and disability pension). Sickness benefit and disability pension will also be analyzed separately. The analyses will be repeated for outcomes on registered sick leave at a three-years follow-up |
At baseline and 12 months after baseline.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in self-reported sickness absenteeism during the 12 months follow-up period
Time Frame: At baseline and during monthly follow-ups for a period of 12 months
|
Self-report data obtained every four weeks during the 12-months follow-up period. These data also include short spells of sick leave. Possible interaction effects on the primary and secondary outcomes for (1) gender x treatment (intervention) and (2) sick leave status (sick leave/no sick leave) x treatment will be checked for and if statistically significant subgroup analyses will be considered. |
At baseline and during monthly follow-ups for a period of 12 months
|
The prevalence of no sick leave, part-time sick leave and full-time sick leave during the 12 months follow-up period following baseline
Time Frame: Twelve months after baseline
|
Change from baseline in self-reported data (no sick leave, 25%, 50%, 75% or 100% sick leave) obtained every fourth week during a follow-up period of 12 months
|
Twelve months after baseline
|
Among those sick listed at baseline: Time to full Return to Work (RTW) during a follow-up period of 12 months
Time Frame: At baseline and during monthly follow-ups for a period of 12 months
|
RTW will be calculated from the study inclusion date until the individual returns in ordinary hours of work during an uninterrupted period of at least four weeks.
Self-reported data obtained every fourth week during a follow-up period of 12 months.
|
At baseline and during monthly follow-ups for a period of 12 months
|
Among those sick listed at baseline: Time to Return to Work (RTW) during a follow-up period of 12 months
Time Frame: At baseline and during monthly follow-ups for a period of 12 months
|
RTW will be calculated from the study inclusion date until the individual returns to work in any increased level (25%, 50%, 75% or 100%).
Self-reported data obtained every fourth week during a follow-up period of 12 months.
|
At baseline and during monthly follow-ups for a period of 12 months
|
Work performance impairment due to health problems
Time Frame: Will be assessed at baseline and once a month during a 12-month follow-up period
|
Change from baseline in work performance as assessed by a question based on one item from the Work Productivity Activity Impairment - General Health Questionnaire (response format from 0-10).
|
Will be assessed at baseline and once a month during a 12-month follow-up period
|
Work performance impairment due to problems in working environment
Time Frame: Will be assessed at baseline and every other month (eighth weeks intervals) during a 12-month follow-up period
|
Change from baseline in work performance as assessed by a question based on one item from the Work Productivity Activity Impairment - General Health Questionnaire (response format from 0-10).
|
Will be assessed at baseline and every other month (eighth weeks intervals) during a 12-month follow-up period
|
Cost-effectiveness of the intervention compared to treatment as usual.
Time Frame: At 12 months after baseline
|
The cost-effectiveness of the intervention will be calculated with regard to production loss (sick leave and performance while at work).
|
At 12 months after baseline
|
Work satisfaction
Time Frame: Will be assessed at baseline and after 6 and 12 months.
|
Change from baseline in self-reported work satisfaction will be assessed by a single item (response format from 0-10).
|
Will be assessed at baseline and after 6 and 12 months.
|
Work ability index (WAI)
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
Change from baseline in self-reported work ability as assessed by two items from WAI (response format from 1-5).
The items relate to perceived capacity to work relative to the physical (1 item) and mental (1 item) demands of the work.
|
Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
Sickness presenteeism
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
Change from baseline in sickness presenteeism is assessed with a single question (response format from 1-4).
|
Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
The Institute of Stress Medicine's instrument for self-rating of stress-related Exhaustion Disorder (s-ED)
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
Change from baseline in self-reported exhaustion on the s-UMS (two yes/no items and one item with a response format from 0-2.
|
Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
Maslach Burnout Inventory - General Survey, Exhaustion-scale
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
Change from baseline in self-reported exhaustion as assessed by the MBI-GS's exhaustion scale (response format from 0 to 6).
|
Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
Hospital Anxiety and Depression Scale
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
Change from baseline in self-reported mental health as assessed by the Hospital Anxiety and Depression Scale (response format from 0-3).
|
Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
Self-perceived health
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
Change from baseline in self-perceived health will be assessed with a single question (response format from 1-5).
|
Will be assessed at baseline and after 6 and 12-months of study inclusion.
|
European Quality of Life - 5 Dimensions questionnaire (EQ-5D)
Time Frame: Will be measured at baseline and after 6 and 12-months of study inclusion.
|
Change from baseline in self-assessed health as assessed by EQ-5D (response format from 1-3).
|
Will be measured at baseline and after 6 and 12-months of study inclusion.
|
Self-reported stress
Time Frame: At baseline and every other month (eighth weeks intervals) during a follow-up period of 12 months
|
Change from baseline in self-reported stress as assessed by a single item (response format from 1-5).
|
At baseline and every other month (eighth weeks intervals) during a follow-up period of 12 months
|
Karolinska Sleep Questionnaire, Insomnia sub-scale
Time Frame: Will be measured at baseline and after 6 and 12-months of study inclusion.
|
Change from baseline in self-assessed sleeping problems as assessed by the Insomnia subscale of the Karolinska Sleep Questionnaire (response format from 1-6).
|
Will be measured at baseline and after 6 and 12-months of study inclusion.
|
Demand-control-support model. Prognostic variable.
Time Frame: Baseline and at 6 and 12 months of study inclusion
|
Change from Baseline at 6 and 12 months (response format from 1-4).
|
Baseline and at 6 and 12 months of study inclusion
|
Other work related variables such as ongoing conflicts with the superior, perceived loss of control over work tasks and conflicts between the employee´s values and how the work actually is done. Prognostic variables.
Time Frame: Baseline and at 6 months after study inclusion
|
Change from baseline at 6 and 12 months after baseline (Likert-type scales with 3 to 5 response options).
|
Baseline and at 6 months after study inclusion
|
Physical activity. Prognostic variable.
Time Frame: At 6 and 12 months after intervention
|
Physical activity will be assessed by a single item.
Response options: 0 minutes, less than 30 minutes, 30-60 minutes, 60-90 minutes, 90-120 minutes or more than 120 minutes.
|
At 6 and 12 months after intervention
|
Change in work conditions. Prognostic variable.
Time Frame: At 6 and 12 months after intervention
|
Possible changes to the participant's work conditions will be asked by a single item with 12 choices.
|
At 6 and 12 months after intervention
|
Change in the organization. Prognostic variable.
Time Frame: At 6 and 12 months after intervention
|
Possible changes in the organization over the past six months are assessed with four response options.
|
At 6 and 12 months after intervention
|
Participants' satisfaction and experiences with the intervention or treatment as usual will be assessed at 6 months after completed intervention by eleven items (response format from 0-10 or yes/no/do not know). Process evaluation data.
Time Frame: Will be assessed 6 months after intervention.
|
These items referred to aspects such as quality of the communication with the OHS personnel, relevance of the intervention, perceived problem-solving skills learned during the intervention, planned adjustments at work, agreement with the supervisor, the implementation of planned adjustments, if follow-up contacts with the OHS have been undertaken and questions regarding treatment satisfaction).
|
Will be assessed 6 months after intervention.
|
OHS staff's adherence to the intervention (process evaluation data)
Time Frame: Assessed at the end of the 12-18 months long recruitment period
|
Self-reported data, single items.
|
Assessed at the end of the 12-18 months long recruitment period
|
Implementation of the intervention and entire research project at the OHS units (process evaluation data)
Time Frame: Assessed at the end of the 12-18 months long recruitment period
|
Self-report data, single items and focus group interviews
|
Assessed at the end of the 12-18 months long recruitment period
|
Three years follow-up: Change from Baseline in registered sickness absenteeism during a 3-year follow-up period
Time Frame: At baseline and 3 years after baseline.
|
Total sick leave in days, register data (sickness benefit and disability pension). The analyses will be conducted in accordance with the 12-month follow-up. |
At baseline and 3 years after baseline.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gunnar Bergström, PhD, Karolinska Institutet
Publications and helpful links
General Publications
- Bergstrom G, Lohela-Karlsson M, Kwak L, Bodin L, Jensen I, Torgen M, Nybergh L. Preventing sickness absenteeism among employees with common mental disorders or stress-related symptoms at work: Design of a cluster randomized controlled trial of a problem-solving based intervention versus care-as-usual conducted at the Occupational Health Services. BMC Public Health. 2017 May 12;17(1):436. doi: 10.1186/s12889-017-4329-1.
- Keus van de Poll M, Nybergh L, Lornudd C, Hagberg J, Bodin L, Kwak L, Jensen I, Lohela-Karlsson M, Torgen M, Bergstrom G. Preventing sickness absence among employees with common mental disorders or stress-related symptoms at work: a cluster randomised controlled trial of a problem-solving-based intervention conducted by the Occupational Health Services. Occup Environ Med. 2020 Jul;77(7):454-461. doi: 10.1136/oemed-2019-106353. Epub 2020 Apr 14.
- Keus Van De Poll M, Bergstrom G, Jensen I, Nybergh L, Kwak L, Lornudd C, Lohela-Karlsson M. Cost-Effectiveness of a Problem-Solving Intervention Aimed to Prevent Sickness Absence among Employees with Common Mental Disorders or Occupational Stress. Int J Environ Res Public Health. 2020 Jul 20;17(14):5234. doi: 10.3390/ijerph17145234.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-2544/2014
- 2014-0742 (Other Grant/Funding Number: Swedish Research Council for Health,Working Life and Welfare)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Common Mental Disorders and/or Stress Related Symptoms
-
Mental Health Services in the Capital Region, DenmarkCentral Denmark Region; Københavns Kommune; The Danish Agency for Labour Market... and other collaboratorsCompletedPersonality Disorders | Depression | Stress | Anxiety | Common Mental Disorders | Functional Disease PresentDenmark
-
Chang Bing Show Chwan Memorial HospitalUnknown
-
University Hospital, GrenobleCompletedQuality of Life | Post Traumatic Stress Disorder | Avalanche, Landslide, or MudslideFrance
-
Yfat Weinstein-ZoharMaccabi Healthcare Services, IsraelUnknownPost-Traumatic Stress DisordersIsrael
-
Centre Hospitalier Universitaire VaudoisUniversity of Zurich; University Hospital, Geneva; University of Lausanne; University...CompletedPosttraumatic Stress Disorder | Acute Stress DisorderSwitzerland
-
Dana-Farber Cancer InstituteEnrolling by invitationStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
Centre Hospitalier Universitaire VaudoisRecruitingPost Traumatic Stress DisorderSwitzerland
-
King's College LondonCompletedAlcohol Use Disorder | Common Mental DisordersUnited Kingdom
-
Erasmus Medical CenterUniversity of Amsterdam; Erasmus University Rotterdam; Delft University of Technology and other collaboratorsUnknownDepression | Posttraumatic Stress Disorder (PTSD)Netherlands
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorders | Depressive Symptoms | Substance-related DisordersUnited States
Clinical Trials on Problem-solving based intervention
-
University of Santiago de CompostelaMinistry of science and innovation of SpainActive, not recruiting
-
Rosalind Franklin University of Medicine and ScienceMedical College of Wisconsin; Children's Hospital and Health System Foundation...UnknownInflammatory Bowel DiseaseUnited States
-
Centers for Disease Control and PreventionUnknown
-
Stanford UniversityNational Institute of Mental Health (NIMH)CompletedHealth BehaviorUnited States
-
Massachusetts General HospitalBeth Israel Deaconess Medical Center; Emory UniversityTerminated
-
Beth Israel Deaconess Medical CenterDartmouth-Hitchcock Medical Center; National Space Biomedical Research InstituteCompletedDepressionUnited States
-
University of WashingtonU.S. Department of EducationCompletedBrain InjuriesUnited States
-
VA Office of Research and DevelopmentActive, not recruitingDepressionUnited States, Puerto Rico
-
Uskudar UniversityHacettepe UniversityCompletedDiabetes Mellitus, Type 2 | Occupational TherapyTurkey
-
University of Alabama at BirminghamNational Eye Institute (NEI)Completed